Aclarion Inc
NASDAQ:ACON

Watchlist Manager
Aclarion Inc Logo
Aclarion Inc
NASDAQ:ACON
Watchlist
Price: 5.88 USD -4.23% Market Closed
Market Cap: 3.9m USD

Aclarion Inc
Short-Term Investments

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Aclarion Inc
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Aclarion Inc
NASDAQ:ACON
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Short-Term Investments
$5B
CAGR 3-Years
32%
CAGR 5-Years
39%
CAGR 10-Years
36%
Inspire Medical Systems Inc
NYSE:INSP
Short-Term Investments
$209.7m
CAGR 3-Years
179%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Short-Term Investments
$706.1m
CAGR 3-Years
1%
CAGR 5-Years
79%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Short-Term Investments
$25.2m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aclarion Inc
Glance View

Market Cap
3.9m USD
Industry
Health Care

Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.

ACON Intrinsic Value
Not Available

See Also

Back to Top